Labshake search
Citations for Tocris :
1 - 50 of 906 citations for 6 Isobutoxy 5 methylpyridine 3 boronic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
Dopamine depletion can be predicted by the aperiodic component of subthalamic local field potentialsbioRxiv - Neuroscience 2021Quote: ... 4 or 8 μl of 6-OHDA (5 μg in 1 μl saline containing 0.1% ascorbic acid; Tocris, Bristol ...
-
bioRxiv - Neuroscience 2020Quote: ... 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl] phenyl isoquinolinesulfonic acid ester (KN-62; Tocris and HelloBio); D-AP5 (HelloBio) ...
-
bioRxiv - Microbiology 2024Quote: To investigate the impact of gallein (3’,4’,5’,6’-Tetrahydroxyspiro[isobenzofuran-1(3H),9’- (9H)xanthen]-3-one) (Cat#3090, Tocris, Minneapolis, MN) and/or INH on Mtb growth ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris) and mounted in modified rose chambers ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris). For monastrol arrest and release experiments ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris).
-
Reduced Hippocampal Inhibition and Enhanced Autism-Epilepsy Comorbidity in Mice Lacking Neuropilin 2bioRxiv - Neuroscience 2021Quote: ... kynurenic acid (3 mM KyA, Tocris, Ellisville, MO) in the recording aCSF ...
-
bioRxiv - Cell Biology 2020Quote: ... Cyclopiazonic-acid (CPA) and 2’(3’)-O-(4-Benzoylbenzoyl)adenosine-5’-triphosphate (BzATP) triethylammonium salt was purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-Isopropoxy-9-xanthone-2-carboxylic acid (AH6809, 10 µM, Tocris); N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251 ...
-
bioRxiv - Molecular Biology 2023Quote: ... IPA-3 (Tocris, 3622, 5 μM), CK666 (Tocris ...
-
bioRxiv - Neuroscience 2020Quote: ... animals were exposed to 10mM 6-OHDA/2mM ascorbic acid (Tocris Bioscience) for one-hour at 20°C ...
-
bioRxiv - Neuroscience 2024Quote: ... VU0360172 [N-cyclobutyl-6-(2-(3-fluorophenyl)ethynyl) pyridine-3-carboxamide] was purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5; Tocris) to isolate synaptic inhibitory transmission ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris #I-440-01M) and mounted in modified rose chambers ...
-
bioRxiv - Neuroscience 2019Quote: ... D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) and STR were added to the bath solution to block AMPA ...
-
bioRxiv - Cell Biology 2021Quote: ... L-2-amino-5-phosphonovaleric acid (AP5, Tocris Bioscience) were included in the bath solution to prevent recurrent activities.
-
bioRxiv - Neuroscience 2022Quote: ... and d-(−)-2-amino-5-phosphonopentanoic acid (APV, Tocris) were added to the ACSF ...
-
bioRxiv - Neuroscience 2024Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris), tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid (APV, 50 μM, Tocris) was added to the ACSF to avoid the unintended N-methyl-D-aspartate receptor (NMDAR ...
-
bioRxiv - Neuroscience 2019Quote: ... 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris). All these compounds were applied in the recording chamber for at least 10 minutes before continuing measurements ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2022Quote: ... 3,5-dichloro-N-[[(1α,5α,6-exo,6α)-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]-benzamide-hydrochloride (ML218 or ml) was purchased from TOCRIS and initially dissolved at 50 mM in DMSO ...
-
bioRxiv - Physiology 2022Quote: ... 50U penicillin and 50U streptomycin) with 3-6 μM CHIR (4423, Tocris). 2 days after initial CHIR addition ...
-
bioRxiv - Neuroscience 2020Quote: ... (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione (ACET; 1μM; Tocris Bioscience, catalog #2728).
-
bioRxiv - Neuroscience 2021Quote: ... and 40 µM D(−)-2-amino-5-phosphonovaleric acid (APV; Tocris) and 50 nM of rat CGRP or vehicle ...
-
bioRxiv - Neuroscience 2021Quote: ... DL-2-Amino-5-phosphonopentanoic acid (DL-AP5, 40 µM, Tocris), bicuculline methiodide (Bic ...
-
bioRxiv - Genomics 2022Quote: ... and 100μM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) overnight to reduce endogenous neuronal activity prior to stimulation ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Neuroscience 2022Quote: ... D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105), and BI2536 (Selleckchem #S1109) ...
-
bioRxiv - Biochemistry 2024Quote: ... 25 μM d-(−)-2-amino-5-phosphonovaleric acid (D-AP5, Tocris), and 100 μM picrotoxin (Nacalai Tesque ...
-
bioRxiv - Neuroscience 2022Quote: 5-[2-Chloro-6-(trifluoromethoxy)phenyl]-1,3-dihydro-2H-benzimidazol-2-one (JNJ-5; Tocris, Minneapolis, MN) is a high affinity ...
-
bioRxiv - Neuroscience 2019Quote: ... and DL-2-amino-5-phosphonopentanoic acid (AP5, 50 μM; Tocris Bioscience). Data files were recorded in two-minute increments in order to establish the baseline recording before bath application of ethanol ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Neuroscience 2022Quote: ... 20 μM CNQX and 5 μM 5,7-DiCl-kynurenic acid (Tocris, UK). For whole-cell GABAR-mediated currents ...
-
bioRxiv - Cell Biology 2022Quote: ... The FFA2R antagonist CATPB ((S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trifluoromethyl)-phenyl) butanoic acid) was from Tocris (Britsol, UK).
-
bioRxiv - Cancer Biology 2019Quote: ... ADORA2b selective antagonist 4-(2,3,6,7-Tetrahydro-2, 6-dioxo-1-propyl-1H-purin-8-yl)-benzenesulfonic acid (PSB1115) (Tocris) (Lin et al. ...
-
bioRxiv - Neuroscience 2019Quote: ... (3S)-3-[[3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartic acid (TFB-TBOA) was purchased from Tocris (Minneapolis, MN; Cat# 2532). All other chemicals were purchased from MilliporeSigma (Burlington ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid / AP5 (Tocris Bioscience). Coverslips were mounted in an RC-21BRFS chamber (Warner Instruments ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... DL-2- amino-5-phosphono-pentanoic acid (AP5; 50 µM; Tocris, Item# 0105), 4-Aminopyridine (4- AP ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...